2019 Sep;11(9):2073
Martinez DL, Tsuchiya Y, Gout I
Whether due to reaching health goals, side effects, or cost concerns, discontinuing the medication can bring questions and challenges
For example, in clinical trials of semaglutide 2.4 mg (Wegovy), nausea occurred in approximately 44% of patients, while rates for tirzepatide and other GLP-1s vary: Nausea : Often described as mild queasiness, particularly after eating, though some patients experience more pronounced nausea Bloating and abdominal fullness : A sensation of delayed digestion or food sitting heavily in the stomach Changes in bowel habits : Constipation affects approximately 15-30% of patients (varying by medication and dose), while some experience diarrhea or alternating patterns [1] [4] Decreased appetite : Beyond simple fullness, many report a fundamental shift in food thoughts, with reduced cravings and less mental preoccupation with eating Some patients report fatigue or low energy , particularly during the initial weeks
Now, multiple randomized controlled trials (RCTs) in the U.S., France, and India have tested leucovorin in children with autism
Nature 431 , 9971002 (2004)